GGHCX holdings — Invesco Health Care Fund
Invesco Health Care Fund (GGHCX) held 82 positions with net assets of $1.21B as of July 31, 2026, according to its Form N-PORT report to the SEC. Its top 10 holdings make up 48.5% of the fund, led by LLY, JNJ, UNH.
GGHCX top holdings
- LLY Eli Lilly and Co. — 10.59% ($128M)
- JNJ Johnson & Johnson — 6.76% ($81.6M)
- UNH UnitedHealth Group Inc. — 6.17% ($74.4M)
- Invesco Private Prime Fund — 4.67% ($56.3M)
- MRK Merck & Co., Inc. — 4.59% ($55.4M)
- ABBV AbbVie Inc. — 4.03% ($48.6M)
- GILD Gilead Sciences, Inc. — 3.63% ($43.9M)
- ARGX argenx SE — 3.24% ($39.1M)
- CVS CVS Health Corp. — 2.52% ($30.4M)
- WELL Welltower Inc. — 2.34% ($28.2M)
- BTSG BrightSpring Health Services, Inc. — 2.20% ($26.5M)
- RPRX Royalty Pharma PLC — 2.13% ($25.8M)
- CAH Cardinal Health, Inc. — 2.10% ($25.3M)
- GH Guardant Health, Inc. — 2.04% ($24.7M)
- VRTX Vertex Pharmaceuticals Inc. — 2.01% ($24.3M)
- Invesco Private Government Fund — 1.80% ($21.7M)
- AXSM Axsome Therapeutics, Inc. — 1.58% ($19.1M)
- EW Edwards Lifesciences Corp. — 1.56% ($18.9M)
- Invesco Treasury Portfolio — 1.56% ($18.8M)
- TMO Thermo Fisher Scientific Inc. — 1.55% ($18.7M)
- BBIO BridgeBio Pharma, Inc. — 1.43% ($17.3M)
- WAT Waters Corp. — 1.41% ($17.0M)
- IQV IQVIA Holdings Inc. — 1.32% ($15.9M)
- UCBJF U C B S.A. — 1.24% ($15.0M)
- LGND Ligand Pharmaceuticals Inc. — 1.18% ($14.2M)
What are GGHCX's top 10 holdings?
LLY (10.6%), JNJ (6.8%), UNH (6.2%), Invesco Private Prime Fund (4.7%), MRK (4.6%), ABBV (4.0%), GILD (3.6%), ARGX (3.2%), CVS (2.5%), WELL (2.3%).
How many stocks are in GGHCX?
Invesco Health Care Fund reported 82 holdings as of July 31, 2026.
Share classes: GGHCX, GGHYX, GTHCX, GTHIX, GTHRX